Test Research, Inc. (TPE:3030)
Taiwan · Delayed Price · Currency is TWD 282.50
+1.00 (0.36%)
Aug 25, 2026, 1:30 PM CST
Test Research Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 66,495 | 45,235 | 28,818 | 14,811 | 15,047 | 13,819 | |
Market Cap Growth | 39.70% | 56.97% | 94.58% | -1.57% | 8.89% | 1.21% |
Enterprise Value | 64,108 | 44,349 | 27,875 | 13,969 | 14,205 | 12,555 |
Last Close Price | 281.50 | 187.35 | 114.83 | 57.94 | 54.73 | 47.78 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.36 | 18.25 | 15.69 | 14.79 | 7.83 | 11.66 |
Forward PE | - | 7.69 | 7.69 | 7.69 | 7.69 | 7.69 |
PS Ratio | 6.97 | 5.34 | 4.53 | 3.34 | 2.24 | 2.47 |
PB Ratio | 6.83 | 4.71 | 3.48 | 2.06 | 2.07 | 2.27 |
P/TBV Ratio | 6.85 | 4.72 | 3.49 | 2.07 | 2.08 | 2.28 |
P/FCF Ratio | 45.33 | 31.40 | 36.55 | 14.50 | 18.82 | 30.51 |
P/OCF Ratio | 38.56 | 26.19 | 24.85 | 7.89 | 10.26 | 23.37 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.72 | 5.24 | 4.39 | 3.15 | 2.12 | 2.24 |
EV/EBITDA Ratio | 17.61 | 14.04 | 12.75 | 10.59 | 6.28 | 7.52 |
EV/EBIT Ratio | 18.65 | 14.82 | 13.74 | 11.56 | 6.60 | 8.06 |
EV/FCF Ratio | 43.70 | 30.78 | 35.35 | 13.67 | 17.76 | 27.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.04 | 0.02 | 0.03 |
Debt / FCF Ratio | 0.02 | 0.03 | 0.04 | 0.05 | 0.06 | 0.13 |
Net Debt / Equity Ratio | -0.24 | -0.16 | -0.16 | -0.18 | -0.19 | -0.22 |
Net Debt / EBITDA Ratio | -0.66 | -0.49 | -0.59 | -0.99 | -0.61 | -0.82 |
Net Debt / FCF Ratio | -1.63 | -1.07 | -1.63 | -1.27 | -1.74 | -3.02 |
Asset Turnover | 0.71 | 0.76 | 0.67 | 0.49 | 0.78 | 0.75 |
Inventory Turnover | 1.94 | 2.18 | 1.93 | 1.32 | 1.78 | 1.91 |
Quick Ratio | 1.65 | 2.62 | 2.83 | 2.55 | 2.81 | 2.40 |
Current Ratio | 2.16 | 3.45 | 3.74 | 3.44 | 3.75 | 3.53 |
Return on Equity (ROE) | 34.97% | 27.72% | 23.75% | 13.86% | 28.76% | 20.09% |
Return on Assets (ROA) | 16.16% | 16.77% | 13.32% | 8.36% | 15.67% | 12.98% |
Return on Invested Capital (ROIC) | 36.08% | 32.87% | 26.58% | 16.39% | 31.79% | 27.31% |
Return on Capital Employed (ROCE) | 34.40% | 30.20% | 23.70% | 16.20% | 28.40% | 24.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.69% | 5.48% | 6.37% | 6.76% | 12.77% | 8.58% |
FCF Yield | 2.21% | 3.19% | 2.74% | 6.90% | 5.31% | 3.28% |
Dividend Yield | 2.42% | 3.74% | 4.35% | 5.70% | 8.22% | 6.91% |
Payout Ratio | 37.88% | 47.65% | 42.44% | 106.16% | 40.57% | 65.78% |
Buyback Yield / Dilution | 0.04% | 0.02% | 0.03% | 0.10% | -0.08% | -0.01% |
Total Shareholder Return | 2.46% | 3.75% | 4.38% | 5.80% | 8.14% | 6.89% |